Emily L Gilbert

TL;DR: In this article, the authors investigated baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA).

TL;DR: In this paper, the authors investigated factors associated with COVID-19 outcomes in patients with primary systemic vasculitis or polymyalgia rheumatica, and found that patients with these conditions are at high risk for poor COVID19 outcomes due to the treatments used, the potential organ damage caused by primary systemic Vasculitis, and the demographic factors associated associated with the conditions.

TL;DR: The high conscious sedation requirements (HCSR) score, which predicted risk of sedation failure with an AUC of 0.70, can function as a useful tool for physicians when discussing sedation options with patients before endoscopy.

TL;DR: In this paper, the authors examined the association between the receipt of TNF inhibitor monotherapy and the risk of COVID-19-associated hospitalization or death compared with other commonly prescribed immunomodulatory treatment regimens among adult patients with IMIDs.

TL;DR: A case of an 83-year-old woman who presented with proximal muscle weakness and erythematous, photosensitive rash of the face and upper torso and was subsequently diagnosed with dermatomyositis based on skin biopsy, electromyography and muscle biopsy is presented.